1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH METHODOLOGY STEPS 21
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 22
2.2.1 SECONDARY RESEARCH 22
2.2.1.1 key data from secondary sources 22
2.2.1.2 Primary research 23
2.2.1.3 Key industry insights 24
2.2.2 KEY DATA FROM PRIMARY SOURCES 25
2.2.3 KEY INSIGHTS FROM PRIMARY SOURCES 26
2.2.4 MARKET SIZE ESTIMATION METHODOLOGY 26
2.3 MARKET FORECAST METHODOLOGY 28
2.4 MARKET DATA VALIDATION AND TRIANGULATION 29
2.5 ASSUMPTIONS FOR THE STUDY 30

3 EXECUTIVE SUMMARY 31
3.1 INTRODUCTION 31
3.2 CONCLUSION 36

4 PREMIUM INSIGHTS 37
4.1 LAPAROSCOPIC INSTRUMENTS: MARKET OVERVIEW 37
4.2 GEOGRAPHIC SNAPSHOT OF THE LAPAROSCOPIC INSTRUMENTS MARKET 38
4.3 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION) 39
4.4 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION (2016 VS. 2021) 39
4.5 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER (2016 VS. 2021) 40


5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.3 MARKET DYNAMICS 43
5.3.1 DRIVERS 43
5.3.1.1 Increasing investments in the laparoscopic instruments market 43
5.3.1.2 Growing number of laparoscopic procedures performed globally owing to increasing preference for minimally invasive surgeries 44
5.3.1.3 Rising prevalence of colorectal cancer 46
5.3.1.4 Increasing number of laparoscopic bariatric procedures 46
5.3.1.5 Technological advancements in the field of laparoscopy 47
5.3.1.6 Growing healthcare markets in emerging economies 48
5.3.2 RESTRAINTS 49
5.3.2.1 Reduced Medicare payments to healthcare providers in the U.S. 49
5.3.2.2 Increasing preference for robotic surgeries as an alternative to laparoscopic procedures 49
5.3.2.3 Dearth of trained professionals in the field of laparoscopy 49
5.3.3 OPPORTUNITIES 50
5.3.3.1 Enhancements in equipment capabilities in laparoscopic instruments 50
5.3.3.2 Increasing number of free-trade agreements 50
5.3.4 CHALLENGE 52
5.3.4.1 Gaps in infrastructural support for laparoscopic procedures in less developed countries 52

6 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT 53
6.1 INTRODUCTION 54
6.2 LAPAROSCOPES 55
6.2.1 VIDEO LAPAROSCOPES 58
6.2.2 FIBER LAPAROSCOPES 59
6.3 ENERGY DEVICES 59
6.4 INSUFFLATORS 61
6.5 SUCTION/IRRIGATION SYSTEMS 62
6.6 CLOSURE DEVICES 63
6.7 HAND INSTRUMENTS 65
6.8 ACCESS DEVICES 67
6.9 ACCESSORIES 69

7 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION 72
7.1 INTRODUCTION 73
7.2 GYNECOLOGICAL SURGERY 74
7.3 GENERAL SURGERY 75
7.4 UROLOGICAL SURGERY 76
7.5 COLORECTAL SURGERY 77
7.6 BARIATRIC SURGERY 78
7.7 PEDIATRIC SURGERY 80

8 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER 82
8.1 INTRODUCTION 83
8.2 HOSPITALS 84
8.3 AMBULATORY SURGICAL CENTERS 85

9 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION 87
9.1 INTRODUCTION 88
9.2 NORTH AMERICA 90
9.2.1 U.S. 93
9.2.1.1 Rise in the number of laparoscopic bariatric surgeries performed 93
9.2.1.2 High incidence of colorectal cancer in U.S. 93
9.2.1.3 Technological advances in laparoscopic instruments 93
9.2.1.4 Rise in geriatric population in the U.S. 94
9.2.2 CANADA 96
9.2.2.1 Availability of physician bonuses 96
9.2.2.2 Incidence of colorectal cancer cases in Canada 96
9.2.2.3 New funding model for Canadian hospitals 96
9.2.2.4 Rise in obesity in Canada promoting bariatric surgeries 97
9.3 EUROPE 99
9.3.1 GERMANY 103
9.3.1.1 Increasing adoption of laparoscopic procedures in urology in Germany 103
9.3.1.2 Minimal out-of-pocket expenditure for medical devices 103
9.3.1.3 Growing aging population and increasing prevalence of prostate cancer 104
9.3.2 U.K. 106
9.3.2.1 Governmental initiatives and investments to develop operating rooms in the U.K. 106
9.3.2.2 High hospital bed occupancy and average length of stay (ALOS) 107
9.3.3 FRANCE 109
9.3.3.1 Favorable government support and growing geriatric population 109
9.3.4 ROE 111
9.3.4.1 Large volume of laparoscopic procedures performed across Europe 111
9.3.4.2 Improving healthcare infrastructure in Russia 114
9.3.4.3 Rise in geriatric population in Italy 114
9.3.4.4 Slow growth of the medical devices and instruments market in Spain 114


9.4 ASIA-PACIFIC 117
9.4.1 JAPAN 120
9.4.1.1 Favorable environment for the growth of the laparoscopic instruments market 120
9.4.1.2 Japan’s Revitalization Strategy (2013) providing an impetus to market growth 120
9.4.2 CHINA 123
9.4.2.1 Penetration of key players into the Chinese market 123
9.4.2.2 Preference for laparoscopic procedures 123
9.4.3 INDIA 126
9.4.3.1 Increasing infrastructural support for laparoscopic procedures in India 126
9.4.3.2 Training institutes in India for continuing medical education 128
9.4.4 ROAPAC 131
9.4.4.1 Asian countries?leading medical tourism destinations 131
9.4.4.2 Growing number of hospitals in Singapore and South Korea 131
9.4.4.3 Application of laparoscopic procedures for diagnosis and treatment of gastric cancer 132
9.4.4.4 Stringent regulations limiting the growth of the market in Indonesia 132
9.4.4.5 German-Asian Partnerships Stimulating Market Growth in Asia 133
9.4.4.6 Favorable healthcare system in Australia 133
9.5 ROW 135
9.5.1 LATIN AMERICA 139
9.5.1.1 Favorable ecosystem for laparoscopic instruments in Brazil 139
9.5.1.2 Government funding to improve surgical care in Latin America 139
9.5.2 MIDDLE EAST & AFRICA (ME&A) 142
9.5.2.1 Increasing focus on Middle Eastern countries 142
9.5.2.2 Emergence of new hospitals in Africa 142
9.5.2.3 Africa: Education to increase physician skills in laparoscopy 143

10 COMPETITIVE LANDSCAPE 146
10.1 OVERVIEW 146
10.2 MARKET SHARE ANALYSIS 147
10.2.1 KARL STORZ GMBH CO. KG 148
10.2.2 OLYMPUS CORPORATION 148
10.2.3 MEDTRONIC PLC 149
10.2.4 AESCULAP 150
10.2.5 STRYKER CORPORATION 150
10.3 COMPETITIVE SITUATION AND TRENDS 151
10.3.1 NEW PRODUCT LAUNCHES 151
10.3.2 EXPANSIONS 152
10.3.3 AGREEMENTS, ALLIANCES, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS 153
10.3.4 ACQUISITIONS 154
10.3.5 OTHER STRATEGIES 155

11 COMPANY PROFILES 156
11.1 INTRODUCTION 156
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*
11.2 ETHICON, INC. 157
11.3 OLYMPUS CORPORATION 160
11.4 KARL STORZ GMBH & CO.KG 162
11.5 STRYKER CORPORATION 164
11.6 RICHARD WOLF GMBH 167
11.7 MICROLINE SURGICAL, INC. 169
11.8 SMITH & NEPHEW PLC 172
11.9 MEDTRONIC PLC 174
11.10 COOK MEDICAL INC. 178
11.11 CONMED CORPORATION 180
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 182
12.1 DISCUSSION GUIDE 182
12.2 COMPANY DEVELOPMENTS (2013-2016) 186
12.2.1 MEDTRONIC PLC 186
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 187
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 189
12.5 AVAILABLE CUSTOMIZATIONS 190
12.6 RELATED REPORTS 191